Results 131 to 140 of about 2,433,705 (252)

Prevalence of HBV DNA in anti-HBe+ chronic HBV carriers in Babol, 2002

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2004
Background and Objective: One of the most important mutations, which occur in hepatitis B virus, is precore mutant. This mutation is associated with highly productive infection in anti-HBe+ chronic HBV carriers. These chronic HBV carriers are predisposed
MR Hassanjani Roshan, MJ Soleimani, A Asghar Zadeh Ahmadi   +2 more
doaj  

Postpartum TDF continuation in high HBV-DNA mothers: safety for breastfeeding and enhanced infant immunity. [PDF]

Front Pediatr
Han D, Gen X, Wang W, Du J, Chu W, Xiao H, Zhang Y.   +6 more
europepmc   +1 more source

The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection. [PDF]

Curr HIV/AIDS Rep
Mani M, Thio CL, Balagopal A.
europepmc   +1 more source

Comparison of novel DiaRD-HBV DNA qPCR kit with the <i>artus</i> HBV QS-RGQ kit for quantification of HBV DNA in clinical samples. [PDF]

Turk J Med Sci
Çuhaci Ü, Toptan H, Durmaz B, Köroğlu M, Durmaz R.   +4 more
europepmc   +1 more source

Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication. [PDF]

J Med Virol, 2023
Zhang J, Zhang Y, Khanal S, Cao D, Zhao J, Dang X, Nguyen LNT, Schank M, Wu XY, Jiang Y, Ning S, Wang L, El Gazzar M, Moorman JP, Guo H, Yao ZQ.   +15 more
europepmc   +1 more source

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection

Alimentary Pharmacology and Therapeutics, 2018
L. Kuhnhenn, B. Jiang, A. Kubesch, J. Vermehren, V. Knop, S. Susser, J. Dietz, G. Carra, F. Finkelmeier, G. Grammatikos, S. Zeuzem, Christoph Sarrazin, Eberhard Hildt, K. Peiffer   +13 more
semanticscholar   +1 more source

A Highly Sensitive Silicon Nanowire Array Field Effect Transistor Biosensor for Detecting HBV-DNA and AFP. [PDF]

Sensors (Basel)
Sun P, Liu M, Zhang Y, Liu C, Yang X.
europepmc   +1 more source

A single-cell digital PCR method tailored for quantification of HBV DNA positive cells in liver biopsy tissues. [PDF]

J Transl Med
Li J, Li H, Zhang X, Liu X, Zhou Z, Wei J, Zhao R, Zhou TC, Zhang Z, Li C.   +9 more
europepmc   +1 more source

A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor. [PDF]

Cell Death Discov, 2023
Furutani Y, Hirano Y, Toguchi M, Higuchi S, Qin XY, Yanaka K, Sato-Shiozaki Y, Takahashi N, Sakai M, Kongpracha P, Suzuki T, Dohmae N, Kukimoto-Niino M, Shirouzu M, Nagamori S, Suzuki H, Kobayashi K, Masaki T, Koyama H, Sekiba K, Otsuka M, Koike K, Kohara M, Kojima S, Kakeya H, Matsuura T.   +25 more
europepmc   +1 more source

Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients. [PDF]

PLoS One
Chen L, Lu Z, Zhang X, Lai J, Huang G, Zheng Y.   +5 more
europepmc   +1 more source